Etihad Cargo teams up with B Medical Systems to develop passive temperature-controlled solution for the transportation of life-saving drugs, vaccines and high-value pharmaceuticals

Etihad Cargo, the cargo and logistics arm of Etihad Aviation Group, has entered into a memorandum of understanding (MOU) with B Medical Systems to develop and launch an airline-specific passive temperature-controlled solution for the transportation of life-saving drugs, vaccines and high-value pharmaceuticals.

Etihad Cargo will collaborate with Luxembourg-based manufacturer and global distributor of medical refrigeration devices B Medical Systems to develop sustainable temperature-controlled container units that utilise passive cooling technology to retain temperatures from -80 to 25 degrees Celsius for up to five days without requiring an external power source,  thereby reducing carbon emissions, with load capabilities ranging from two to 1,500 litres. The containers’ robust design and multi-use capabilities enable an operational life of over ten years.

Dr. Omar Najim, Manager Executive Affairs Office at DoH, Andrea Scammacca, COO, B Medical, Jesal Doshi, CEO, B Medical, H.E. Abdullah bin Mohammed Al Hamed, Chairman of Department of Health, Dr Nadia Al Bastaki, Chief HROD, Etihad Aviation Group, Tim Isik, VP, Etihad Cargo, Lubna AlLaham, Marketing & Communications, Etihad Cargo, Fabrice Panza, Cool Chain Products, Etihad Cargo

Etihad Cargo is participating in the BIO International Convention as part of a high-profile Abu Dhabi delegation headed by H.E. Abdulla bin Mohammed Al Hamed, Chairman of the Department of Health – Abu Dhabi (DoH). The delegation is visiting the USA to explore prospects for collaboration within the healthcare sector and, more specifically, life sciences to establish sustainable mechanisms that empower the healthcare sector in both countries as well as showcase Abu Dhabi’s distinguished healthcare ecosystem.

Powered by a solid infrastructure and advanced healthcare ecosystem, partnership opportunities across the biopharmaceutical and healthcare value chain in Abu Dhabi continue to emerge as a result of the sector’s robust growth potential. Abu Dhabi has been leading the transformation of the regional healthcare ecosystem by leveraging sciences and technology, positioning itself as a global life sciences hub and incubator for healthcare innovation.